Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial. - Yang Y; He Y; Fan Z; Chen X; Liu Y; Zhang C; Jiang H; Wang X; Xie F; Wang S; Luo B; Kang H; et al. (NPJ breast cancer, 2023)